Resources and Information

»Pharmacology Update

Dec 06 2018

PREDIMED Study

Janet Swartz, EdD

During a recent webinar, Dr. Jim Thimons discussed an article about the PREDIMED Trial published in JAMA Ophthalmology that evaluated the impact of Omega-3 fatty acids on diabetic retinopathy.
read more

discuss

 

»Industry News

Dec 06 2018

Nuretin Omega-3 Supplements

Janet Swartz, EdD

PRN has developed nuretin, an omega-3 supplement, to delay the onset and slow the progression of diabetic retinopathy.
read more

discuss

 

»Case of the Month

Dec 03 2018

Vascular Issues in Glaucoma

Bud O'Leary, OD

Dr. Eric Conley discusses how a vein occlusion in one eye can affect visual fields and RNFL in both eyes.
read more: Full Members Only

 

»Webinars

Nov 07 2018

Using an OCT to Detect Progression

Janet Swartz, EdD

Dr. Eric Schmidt discusses progression in glaucoma management and the value of using an OCT to assess changes in the RNFL before visual field loss occurs.
read more

discuss

 

»Webinars

Oct 23 2018

Corneal Hysteresis Measurement

Janet Swartz, EdD

Dr. Jim Thimons discusses corneal hysteresis, a valuable new technology in glaucoma management.
read more

discuss

 

»Clinical Guidelines

Oct 16 2018

CyPass Clinical Recommendations

J. James Thimons, OD, FAAO

ASCRS (American Society of Cataract and Refractive Surgery) has released information related to the CyPass Stent and its recall.
read more

discuss

 

»Industry News

Aug 29 2018

Alcon Withdraws CyPass Stents

J. James Thimons, OD, FAAO

Alcon announces a voluntary withdrawal of all CyPass stents.
read more

discuss

 

»Glaucoma Watch

Aug 08 2018

DREAM Study

Bud O'Leary, OD

The DREAM study of dry eye was discussed as part of a lecture at the National Glaucoma Symposium. However, the NIH-funded study has received some criticism for the conclusion about the effectiveness of omega-3 supplements versus olive oil as the placebo.
read more

discuss

 

 

previous